UK Health Minister Ivan Lewis has outlined proposals to improve the quality of dementia care and provide more help for people with the condition, as he launched a consultation on the first ever National Dementia Strategy. Direct costs of dementia care to Britain's National Health Service are estimated to be in the region of L3.3 billion ($6.48 billion), with the amount spent on drugs for this in England alone put at some L60.9 million.
With the full Strategy to be launched in the fall, the governments announcement includes a number of immediate actions, as well as other proposals which will be consulted on over the coming months. These include:
- an immediate review into the prescribing and use of antipsychotic drugs to treat sufferers of dementia. This work will be completed before the publication of the complete National Dementia Strategy.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze